New clinical trials recruitment model powered by AI, blockchain launched in PHL
REVOLUTIONIZING medical research in the country, the Philippine Alliance of Patient Organizations (PAPO) has teamed up with Care.trials Inc. (CTI) to launch a new model of patient engagement in clinical trials with the use of artificial intelligence (AI) and blockchain technologies.
With their partnership, CTI’S solution is designed in a way that even a grandmother can explore it in just a couple of minutes. It features anonymous browsing of trials; simple mechanisms for liking and connecting with trials; pre-screening capabilities; unbiased advocacy; and a strict no pressure policy, ensuring no unsolicited emails or messages.
According to CTI Chief Executive Officer Pradeep Goel, their tie up is meant to connect patients directly with clinical trial research, while ensuring their privacy and engagement as well as producing efficient outcomes. Together, they reinvent the enrollment process for clinical studies, making it more efficient for both patients and research teams.
“[It is] a whole new approach that is rooted in empowering and engaging the patient without mining their data and earning patient trust by protecting them and advocating on their behalf,” he said. “At the same time, we bring powerful new tools to study teams to identify and connect with the right patient and effectively determine if they are suitable and eligible to participate. Our goal is to accelerate research such that cures for all diseases can be found faster.”
For PAPO President Karen Alparce-villanueva, their collaborative effort signifies their mission to empower Filipino patients by arming them with the right tools they need to advocate for their rights and actively get involve in their health care.
“By integrating Care. trials’ innovative technology, we are enhancing our network’s strength and activity, enabling patients to become more informed and productive members of society,” she noted.
What comes next
BEING a leading group championing for patient rights and welfare in the Philippines, PAPO serves as a strong and active network of patient groups that empowers more than 50 disease-specific groups of patients nationwide. It works with healthcare providers, policymakers, and industry leaders to make sure that the voices of patients are heard and acted upon.
Sharing the same vision with PAPO, CTI seeks to revolutionize the way individuals access and participate in clinical trials. This global firm operates the Care.trials Network. CTI’S Care.trials is a powerful new technology that protects and implements patient privacy and rights, and achieves high levels of trust and engagement. By leveraging AI and blockchain, patients are able to exercise total control over their identity, data and decisions.
Following their partnership, PAPO and Care.trials will work closely to empower and engage the 3.8 million member-patients that the former represents, providing them with unprecedented tools for access, engagement, and participation in relevant research.